The Discounted Cash Flow (DCF) valuation of Rigel Pharmaceuticals Inc (RIGL) is 36.74 USD. With the latest stock price at 35.11 USD, the upside of Rigel Pharmaceuticals Inc based on DCF is 4.6%.
Based on the latest price of 35.11 USD and our DCF valuation, Rigel Pharmaceuticals Inc (RIGL) is a buy. buying RIGL stocks now will result in a potential gain of 4.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.9% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 23.63 - 85.45 | 36.74 |
| Upside | -32.7% - 143.4% | 4.6% |